Details
Published:
Banners and Alerts and 3 Roundcube Webmail Inbox

With the LSN Digital RESI Conference approaching quickly, Event Gold Sponsor, BioHealth Innovation (BHI), is stepping up to help lead five panels with some heavy hitters from the BioHealth Capital Region (BHCR) on June 8-10, 2020.

Great Investment Opportunities in the BioHealth Capital Region

While we adjust to a COVID-19 world, there continue to be great investment opportunities in the BioHealth Capital Region. Join BHCR CEOs as they make short introductions about themselves and companies. Join CEOs from American Gene Technologies International Inc., miRecule, Adaptive Phage, Healion Bio, KaloCyte, Emocha, Tailored Therapeutics, Inc., DEKA, and Ashvattha Therapeutics, Inc.

Details
Published:
bendis-headshot-090517-image

We are excited to announce that Rich Bendis of BioHealth Innovation will be the keynote speaker at the 2019 Technology Showcase. Now in its third year, the Technology Showcase promises to be a "must attend" event for biotech stakeholders in Maryland/DC/VA region. Check out the event page to learn more about our keynote speaker and some of the great panel sessions that we have planned.

Make sure to reserve time on your calendar for the afternoon of Wednesday, June 12.

The 2019 Technology Showcase is a half-day event that will showcase technologies being developed at the NCI and the Frederick National Laboratory for Cancer Research (FNLCR) to encourage startup company formation, technology licensing and collaborations. Innovators, entrepreneurs, investors and business development professionals should attend. 

Details
Published:
bhi launch tedco mont county logo

University of Maryland Institute for Bioscience & Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850

Register NOW:  https://tinyurl.com/BHISBIR2019

  • 8:00 a.m. – Networking and Registration
  • 8:30 a.m. – Welcome
  • 8:35 a.m. – SBIR Funding Opportunities at the National Institutes of Health
    • National Heart, Lung, and Blood Institute
    • National Institute on Aging
    • National Institute on Drug Abuse
    • National Cancer Institute  
  • 9:45 a.m. – Partnership Opportunities with NCI Frederick National Lab  
  • 10:00 a.m. – BREAK
  • 10:20 a.m. – SBIR Funding Opportunities with the National Science Foundation    
  • 11:00 a.m. – BREAK  
  • 11:15 a.m. – SBIR Funding Opportunities with USAMRC    
  • 11:45 a.m. –  Lunch  
  • 12:45 p.m. – (1:1 Room Set)  
  • 1:00 p.m. – Writing Your Specific Aims Page OR 1:1 Meetings* (available simultaneously)  
  • 1:30 p.m. – Writing Your Phase II Commercialization Plan OR 1:1 Meetings* (available simultaneously)  
  • 2:00 p.m. – Writing Your Specific Aims Page OR 1:1 Meetings* (available simultaneously)  
  • 2:30 p.m. –  Writing Your Phase II Commercialization Plan  OR 1:1 Meetings* (available simultaneously))  
  • 3:00 p.m. –  1:1 Meetings* (NIH only)  
  • 4:00 p.m. – Adjourn

Pre-Registration REQUIRED: RSVP by noon, February 26 at https://tinyurl.com/BHISBIR2019
No charge for entrepreneurs to attend • NOTE: Most 1:1 meeting(s) timeslots now are booked but when you list your agency interests in the RSVP we will be certain to let them know to follow up with you with more information.

Details
Published:
ReimbursementFlyer 01

  • How do you obtain coverage and payment for your technology?
  • Is the process different for medical devices from diagnostics or therapeutics?
  • Can digital apps be reimbursed?
  • How do I work with bundled payments?
  • What is the process for securing reimbursement codes?  Do I need different strategies based upon the point of care?
  • How much do I need to budget for a reimbursement strategy?  When do I need one?
  • How to I talk to investors about my reimbursement strategy? 

Learn the answers to these questions and more through the November 14th PathFinder Innovation Program. (There is no charge to attend in person or by videoconference, however, pre-registration by NOON, 11/13 is required).

  • 8:15 a.m. Networking and Coffee
  • 8:30 a.m.  – Issues Overview (in person/by videoconference)
    • Speakers:  Brian Abraham, Founder, Lara Reimbursement Advisory
    • Luis Gutierrez, Entrepreneur-in-Residence, NHLBI and BioHealth Innovation
  • 9:30 a.m. – 1:1 Office Hours (in person/by videoconference)*


This program is cosponsored by BioHealth Innovation, Launch Workplaces, TEDCO and Montgomery County. It is open to anyone in the BioHealth Capital Region.  

To register/For more information, email:  BHI@BioHealthInnovation.  (In person 1:1 scheduling:  www.tinyurl.com/BHIappointments.)

*Attendance at Overview in person/by videoconference required to participate in 1:1 sessions.

Details
Published:
childrens-nation-bhi-logo

To foster development, production and marketing of the next generation of medical devices designed to meet growing children’s unique needs, the Food and Drug Administration (FDA) awarded $5 million to the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), led by Children’s National Health System and University of Maryland, College Park. New Consortium members include BioHealth Innovation, Inc., a Maryland-based innovation intermediary that supports the transformation of research projects into new business opportunities, and MedTech Innovator, a California-based virtual startup accelerator that matches health care industry leaders with early-stage and emerging growth medtech companies for mentorship and support. NCC-PDI’s affiliated members include industry leaders such as Smithwise, Epidarex, and Cadence. 

Details
Published:
Inbiaimpactlogo

BioHealth Innovation, Inc. (BHI) has received the International Business Innovation Association (InBIA)’s January 2018 IMPACT Award in Biotech/Cleantech for the management of four spaces for early stage companies: the Germantown Innovation Center, the Rockville Innovation Center, LaunchLabs, and the BHI International Innovation Center.   The award is based on a variety of metrics including affiliations and partnerships, application and graduation, facilities, mission and goals.  This recognition also enables this innovation activity to be considered with other leading entrepreneurial centers across the country as a finalist for the InBIA’s annual Incubator of the Year Awards.  

Details
Published:
emergent-biosolution-logo

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at approximately $8 million to deliver Anthrasil® (Anthrax Immune Globulin Intravenous [human]) to the Canadian government. This contract award follows the recent approval of Anthrasil by Health Canada under the Extraordinary Use New Drug (EUND) Regulations, which provide a regulatory pathway for products for which collecting clinical information for its intended use in humans is logistically or ethically not possible. Anthrasil is indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs.

Details
Published:
affinis-labs-logo

That Indians are not only heading global IT giants like Google and Microsoft but also a number of startups in diverse sectors, including biotechnology, across the US is evident from the fact that of the 52 companies operating out of the two innovation hubs in Rockville and Germantown in Maryland 11 are either headed or run by Indians.

From mobile technology platform connecting doctors and patients to pre-market cybersecurity for IoT (Internet of Things) devices, Indian Americans are the driving force behind several firms at the two innovation hubs managed by BioHealth Innovation, Inc, a non-profit public-private partnership, which aids early stage biotechnology companies from research to commercialization.

Details
Published:
bendis-headshot-090517-image

In 2010, an industry-led task force created in Montgomery County partnered with members of regional academia, government and other nonprofits to create an entrepreneurial innovation ecosystem that wasn’t being filled.

BioHealth Innovation Inc. (BHI), which was founded in 2012 by Richard Bendis in Rockville, Md., is designed to help bio-health companies grow, identify commercially relevant science, create new businesses and attract equity funding to the region. Bendis, who is also the president and CEO, has overseen the organization’s creation of unique programming for entrepreneurs at the National Institutes of Health, the University of Maryland and Johns Hopkins University.

Details
Published:
Bendis AE1

Robust private-sector investment and prudent regulation from policymakers have helped establish Maryland as a cradle of innovation and a leader in the U.S. innovation economy. Few states can match Maryland's highly skilled workforce, market access and technology-centered policy incentives, and the U.S. Chamber of Commerce ranked Maryland No. 1 in the country for entrepreneurship and innovation.

But continued leadership of the region — and the ability of the region to continue to reap the economic and jobs benefits of innovation — is not a given. It requires constant cultivation and smart action from our elected officials.

Maryland is home to more than 800 life sciences companies, 70 federal labs and 16 colleges and universities, including National Institutes of Health, the Food and Drug Administration, Johns Hopkins University, the University System of Maryland and companies like MedImmune and GlaxoSmithKline. About 6 percent of Maryland's gross domestic product — $17.6 billion — is generated by the life sciences, and the biotechnology industry in Maryland alone employs about 34,000.

During the most recent legislative session in Maryland, the General Assembly considered a piece of onerous drug pricing legislation that threatened the biopharmaceutical ecosystem in the state while also potentially impeding access to care for Maryland patients.

In the name of "transparency," the legislation — which would have been the most hostile to industry in the country — imposed complex bureaucratic reporting requirements that disregarded the extraordinary development requirements and complex distribution channels for innovative drugs and therapies.

Read more via the Capital Gazette

Details
Published:

BioHealth Innovation (BHI) is pleased to have the opportunity to discuss the entrepreneurial ecosystem in Maryland and the region.

BHI is a regional innovation intermediary which supports the transformation of research projects into new business opportunities in partnership with the region’s rich assets, institutions, and entrepreneurial community. BHI achieves this goal by being a catalytic partner in the economic development ecosystem which focuses on attracting, retaining, founding and reinventing biohealth businesses. BHI has built the infrastructure and track record to cofound and create new early stage biohealth startup and spinoff companies. In addition, BHI works directly with existing biohealth firms through a variety of supportive services including: incubation and accelerator programs, non-dilutive funding assistance, international soft landing programs and entrepreneur-in-residence support.

Details
Published:
BendisAE

 

The Daily Record has named BioHealth Innovation Inc., (BHI) President and CEO Richard Bendis a 2017 Influential Marylander. Mr. Bendis is one of 51 Influential Marylanders who were selected by the publication for their significant contributions to their respective fields and leadership in the state.

“It’s an honor to be chosen as an Influential Marylander by The Daily Record. BHI has been working with our partners and other key stakeholders to help make Maryland a leader in the BioHealth Capital Region,” said Mr. Bendis. “Our success in supporting over 800 companies, scientists, and entrepreneurs since 2012 is a testament to the hard work and dedication of the entire BHI team.”

Mr. Bendis, along with the other Influential Marylanders, will be presented their awards on March 23, 2017 at a reception and dinner at The Grand Lodge of Maryland. The winners will also be profiled in a special magazine that will be inserted into the March 24th issue of The Daily Record and available online at www.TheDailyRecord.com.

"Influential Marylanders help to shape their communities – our communities – for the better. They are at the pinnacle of their chosen professions and are role models for all of us," said Suzanne Fischer-Huettner, publisher of The Daily Record. "Their hard work, determination and commitment to excellence help us to realize our own hopes and dreams. The Daily Record is honored to recognize their accomplishments."

About BioHealth Innovation, Inc.

BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. BHI is known for providing commercial assistance to scientists and founders, educating and infusing Maryland's life science community with new and young entrepreneurs and fueling startups within Central Maryland's bio-ecosystem by connecting young companies to funding and business resources. Learn more at: www.biohealthinnovation.org

Click here to view all of the 2017 Influential Marylanders Honorees.

Details
Published:
bhi-biohealth-innovation-logo

BioHealth Innovation inked a pair of recent deals to run incubators in Montgomery County.

The Rockville-based organization that works to help health and life sciences startups in the region is set to manage the Germantown Innovation Center and the Rockville Innovation Center. It’s the first foray into running incubators for the public-private partnership, which also helps startups coming out of UMB and Johns Hopkins in Baltimore.